About 6 years ago, under the leadership of Pfizer's CEO and CFO, Pfizer's corporate finance organization embarked on a reengineering initiative to transform its charter, processes, products, and services.
Pfizer has yet to rethink their charter, processes, products, and services, and has no plans to do so in the future.